Belzutifan is a type of medicine that blocks HIF-2α, which helps to fight RCC linked to VHL and decreases the oxygen levels in tumors. It comes in 40 mg pills with a coating.
The recommended dose is 120 mg once daily, with each bottle containing 90 tablets.
Reviews
There are no reviews yet.